company background image
BLGO logo

BioLargo OTCPK:BLGO Stock Report

Last Price

US$0.22

Market Cap

US$67.0m

7D

-5.9%

1Y

-35.5%

Updated

04 May, 2025

Data

Company Financials +

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

US$0.38
FV
41.4% undervalued intrinsic discount
7.99%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
3 days ago author updated this narrative

BioLargo, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioLargo
Historical stock prices
Current Share PriceUS$0.22
52 Week HighUS$0.37
52 Week LowUS$0.16
Beta-0.021
1 Month Change-11.46%
3 Month Change-8.98%
1 Year Change-35.50%
3 Year Change17.11%
5 Year Change61.23%
Change since IPO-68.21%

Recent News & Updates

author-image

PFAS, Battery Tech And Medical Launches Will Shape Markets

Apr 08 Transformative technologies and strategic partnerships could drive substantial revenue growth and improve net margins by reducing investment risks.

Recent updates

author-image

PFAS, Battery Tech And Medical Launches Will Shape Markets

Apr 08 Transformative technologies and strategic partnerships could drive substantial revenue growth and improve net margins by reducing investment risks.

Shareholder Returns

BLGOUS ChemicalsUS Market
7D-5.9%3.1%3.0%
1Y-35.5%-6.8%10.1%

Return vs Industry: BLGO underperformed the US Chemicals industry which returned -7% over the past year.

Return vs Market: BLGO underperformed the US Market which returned 10% over the past year.

Price Volatility

Is BLGO's price volatile compared to industry and market?
BLGO volatility
BLGO Average Weekly Movement7.6%
Chemicals Industry Average Movement7.4%
Market Average Movement7.9%
10% most volatile stocks in US Market16.2%
10% least volatile stocks in US Market4.1%

Stable Share Price: BLGO has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: BLGO's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199142Dennis Calvertwww.biolargo.com

BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company’s technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. It provides full-service environmental engineering services.

BioLargo, Inc. Fundamentals Summary

How do BioLargo's earnings and revenue compare to its market cap?
BLGO fundamental statistics
Market capUS$67.04m
Earnings (TTM)-US$2.40m
Revenue (TTM)US$17.78m

3.8x

P/S Ratio

-27.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLGO income statement (TTM)
RevenueUS$17.78m
Cost of RevenueUS$9.93m
Gross ProfitUS$7.85m
Other ExpensesUS$10.26m
Earnings-US$2.40m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.008
Gross Margin44.17%
Net Profit Margin-13.51%
Debt/Equity Ratio17.8%

How did BLGO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 10:42
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioLargo, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard RyanOak Ridge Financial Services Group Inc.